This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
HCPLive
FEBRUARY 2, 2024
Obesity was linked to an increased risk of focal segmental glomerulosclerosis and hypertensive nephropathy, with further analysis revealing its impact on the risk of developing end-stage kidney disease.
105 
Med Page Today
MARCH 15, 2024
(MedPage Today) -- A computerized clinical decision support (CDS) tool for primary care helped lower blood pressure (BP) in patients with chronic kidney disease (CKD) and uncontrolled hypertension, a cluster-randomized trial found. When primary.
115 
Cardiovascular Diabetology
APRIL 9, 2024
Hypertension and chronic kidney disease (CKD) pose significant public health challenges, sharing intertwined pathophysiological mechanisms. Prediabetes is recognized as a precursor to diabetes and is often acc.
HCPLive
MARCH 26, 2025
Other risk factors in the population included PZA or ETB use, hypertension, heart failure, and chronic kidney disease.
Hypertension Journal
DECEMBER 7, 2023
Hypertension, Ahead of Print. ETs were shown to play important roles among others, in systemic hypertension, particularly when resistant or difficult to control, and in pulmonary hypertension, atherosclerosis, cardiac hypertrophy, subarachnoid hemorrhage, chronic kidney disease, diabetic cardiovascular disease, scleroderma, some cancers, etc.
American College of Cardiology
FEBRUARY 5, 2024
Hypertension represents a major modifiable risk factor for coronary artery disease (CAD), heart failure (HF), stroke, chronic kidney disease (CKD), and dementia.
75 
CardiacWire
MAY 8, 2024
A new JAMA study revealed that a shocking 90% of US adults are at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome, underscoring the need for preventative action before we face a wave of CKM-related heart disease. Stage 4 (heart disease, with or without kidney disease) – 9.2% in Whites).
116 
DAIC
JANUARY 19, 2024
The BACKBEAT pivotal study will evaluate the efficacy and safety of atrioventricular interval modulation (“AVIM”) therapy (also known as BackBeat CNT), for the treatment of pacemaker-indicated patients with uncontrolled hypertension despite the use of antihypertensive medications. Orchestra BioMed and Medtronic, Inc. Kowal, M.D., and Europe.
105 
DAIC
MARCH 26, 2025
2 Most are balancing multiple comorbidities, such as obesity, diabetes, hypertension and chronic kidney disease (CKD). A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease (FIND-CKD). 4 Approximately 6.7 million adults in the U.S. NCT06033950.
Journal of Clinical Investigation - Cardiology
JANUARY 2, 2024
Mineralocorticoid excess commonly leads to hypertension (HTN) and kidney disease. This gene signature also showed a potential for classifying human kidney samples. In our study, we used single-cell expression and chromatin accessibility tools to characterize the mineralocorticoid target genes and cell types.
127 
MIBHS
FEBRUARY 15, 2025
High blood pressure, also known as hypertension, is a common condition that affects millions of people worldwide. Often referred to as the silent killer, hypertension can quietly damage your heart and other vital organs over time. Hypertension is diagnosed when blood pressure consistently reads 130/80 mm Hg or higher.
DAIC
JANUARY 8, 2025
a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases, hasannounced that the U.S. tim.hodson Wed, 01/08/2025 - 14:11 Jan. 8, 2025 Mineralys Therapeutics, Inc.,
Med Page Today
APRIL 3, 2024
(MedPage Today) -- Using a personalized algorithm to identify primary care patients with chronic kidney disease (CKD), type 2 diabetes, and hypertension (the kidney-dysfunction triad) -- plus practice facilitators to help providers deliver guideline.
Frontiers in Cardiovascular Medicine
APRIL 4, 2024
Hypertension is a leading cause of morbidity and mortality worldwide and poses a major risk factor for cardiovascular diseases and chronic kidney disease.
Journal of the American Heart Association
DECEMBER 18, 2023
BackgroundBoth nighttime systolic blood pressure and pulse rate are associated with adverse outcomes in patients with chronic kidney disease (CKD). The DP of nondialysis patients with CKD and hypertension showed a diurnal rhythm, which varied with renal function. Journal of the American Heart Association, Ahead of Print.
Hypertension Journal
SEPTEMBER 14, 2023
Hypertension, Volume 80, Issue 12 , Page 2533-2543, December 1, 2023. BACKGROUND:Hypertension frequently accompanies chronic kidney disease (CKD) as etiology and sequela.
American College of Cardiology
MARCH 22, 2024
Does a computerized clinical decision support (CDS) system based on behavioral economic principles and human-centered design lead to a decrease in systolic blood pressure (SBP) in patients with chronic kidney disease (CKD) and uncontrolled hypertension?
51 
Hypertension Journal
DECEMBER 5, 2024
Hypertension, Ahead of Print. BACKGROUND:Intensive blood pressure (BP) control in youth with chronic kidney disease (CKD) slows progression, delaying the need for kidney replacement therapy (KRT). Most youth with CKD have hypertension and BP control is difficult to achieve outside of controlled experimental settings.
Hypertension Journal
MARCH 6, 2025
Hypertension, Ahead of Print. BACKGROUND:Arterial hypertension (HTN) and type 2 diabetes (T2DM) are contributors to chronic kidney disease leading to glomerulomegaly and podocyte loss. Enlarged glomeruli and podocyte depletion are associated with kidney disease progression.
45 
Stroke Journal
FEBRUARY 1, 2024
Introduction:Chronic kidney disease (CKD) is a well-established risk factor for spontaneous intracerebral hemorrhage (ICH). This association was reduced to a 19% increase in ICH risk after adjusting for hypertension in multivariable MR (OR 1.19; 95% CI 1.03-1.39; 1.71; p=0.002). 1.39; p=0.021).
Circulation
MARCH 9, 2025
Albuminuriaincreased urine albumin excretionis associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heart failure, as well as among adults with few cardiovascular risk factors. Circulation, Volume 151, Issue 10 , Page 716-732, March 11, 2025.
DAIC
JUNE 28, 2024
milla1cf Fri, 06/28/2024 - 19:07 June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa , its flagship health equity initiative, to target a broader range of non-communicable diseases (NCDs), including chronic kidney disease (CKD) as well as hypertension and cardiovascular disease.
111 
Hypertension Journal
NOVEMBER 13, 2024
Hypertension, Volume 82, Issue 1 , Page 14-25, January 1, 2025. Podocyte dysfunction, resulting from oxidative stress, dysregulated prosurvival signaling, or structural damage, can drive the development of proteinuria and glomerulosclerosis in hypertensive nephropathy.
40 
Frontiers in Cardiovascular Medicine
DECEMBER 12, 2024
BackgroundThe association between healthy lifestyle and American Heart Association (AHA) Life's Essential 8 (LE8) score and apparent treatment-resistant hypertension(aTRH)remains uncertain. to 0.20) for uncontrolled hypertension with 12 and 34 antihypertensive drugs, respectively. to 0.76) and 0.07 (95% CI, 0.02
52 
Stroke Journal
JANUARY 30, 2025
Background:Chronic kidney disease (CKD) has emerged as an independent risk factor for cerebral microhemorrhages (CMH). Stroke, Volume 56, Issue Suppl_1 , Page ADP60-ADP60, February 1, 2025. adenine diet to induce CKD, or angiotensin II (ATII) via subcutaneous osmotic pumps to induce HTN and compared with control mice.
HCPLive
JANUARY 8, 2025
Panelists discuss how chronic kidney disease (CKD) and uncontrolled hypertension create a damaging cycle, in which hypertension accelerates kidney damage while declining kidney function makes blood pressure harder to control.
CardiacWire
OCTOBER 27, 2024
It’s well known that heart disease is the U.S.’s s top cause of death, and our rising CVD rates have been widely covered, but a look back on some of the biggest stories of 2024 suggests that cardiovascular disease is about to become a much bigger problem. Hypertension Problems: Another JAMA study highlighted the U.S.’s
59 
Cardiometabolic Health Congress
JULY 10, 2024
Bakris , an internationally recognized and influential nephrologist and hypertension expert, who passed away on June 15, 2024, at the age of 72. Bakris’s distinguished career in medicine spanned over four decades, marked by significant contributions to the fields of diabetic kidney disease, hypertension, and nephropathy progression.
52 
Hypertension Journal
OCTOBER 11, 2023
Hypertension, Volume 80, Issue 12 , Page 2591-2600, December 1, 2023. RESULTS:The median age of the patients was 76 years, and 54.9% were women. The total AHT incidence was 70 cases per 100 000 admission year. Urgent dialysis rates increased from 1.52% (95% CI, 1.12–2.06) 2.06) to 2.60% (2.17–3.1;
40 
HCPLive
DECEMBER 4, 2024
Panelists discuss how poor medication adherence and comorbidities such as chronic kidney disease (CKD) contribute to uncontrolled hypertension despite the availability of numerous treatment options, highlighting key challenges in achieving effective blood pressure management.
Hypertension Journal
FEBRUARY 22, 2024
Hypertension, Ahead of Print. Hypertension is one of the most commonly treated conditions in modern medical practice, but despite its long history, it was largely ignored until the midpoint of the 20th century.
40 
Circulation
NOVEMBER 11, 2024
The diagnosis of hypertension is associated with a significant increase in the risk of kidney or cardiovascular events, with no prior history of these events. Total deaths from hypertensive heart disease and renal disease associated with heart failure were 5,274, showing an increasing trend from 1999 to 2020.
40 Journal of the American Heart Association
DECEMBER 1, 2023
Participants with an RHR of ≥80 bpm had a higher stage of chronic kidney disease, lower estimated glomerular filtration rate, and more proteinuria than those with an RHR of 60 to 69 bpm. Of the participants, 32.6% had an RHR of 60 to 69 beats per minute (bpm), and 22.2% had an RHR of ≥80 bpm. 1.42]) and 64% (HR, 1.64 [95% CI, 1.42–1.90])
75 
Hypertension Journal
NOVEMBER 1, 2023
Hypertension, Ahead of Print.
American College of Cardiology
FEBRUARY 18, 2025
A 65-year-old woman with a history of systemic lupus erythematosus (SLE) treated with prednisone and hydroxychloroquine 300 mg/day for 40 years, stage 3 chronic kidney disease, and hypertension presented to the cardiology clinic with progressive dyspnea on exertion.
Cardiometabolic Health Congress
NOVEMBER 16, 2023
Key findings presented at the conference included disparities in access to kidney transplantation and waitlisting based on race and neighborhood characteristics, racial and ethnic differences in incident chronic kidney disease (CKD), and the use of motivational strategies to improve dialysis nonadherence among African American patients.
Cardiometabolic Health Congress
NOVEMBER 25, 2024
Don’t worry—you can still access the 19th Annual CMHC sessions through our On-Demand platform, which offers 14 CME credits across four comprehensive tracks: Cardiorenal Health: Stay up-to-date with the latest on therapies for resistant hypertension, chronic kidney disease markers, and cardiac risk assessment tools.
52 Stroke: Vascular and Interventional Neurology
MARCH 6, 2024
We aimed to define the prevalence of systemic hypertension in MMD patients and characterize its evolution after cerebral revascularization.METHODSPatients with MMD treated with extracranial‐intracranial bypass from 2014 to 2018 were retrospectively enrolled. 6.04]), kidney disease (OR, 18.98 [95% CI, 1.80–200.47]), respectively.
40 
DAIC
APRIL 7, 2024
High blood pressure, or hypertension , is a leading cause of heart attacks, strokes and death. The KARDIA-2 study tested whether adding zilebesiran to a standard antihypertensive medication would further reduce blood pressure in patients with hypertension who were not achieving adequate bloodpressure control on their existing medication.
111 
Heart BMJ
OCTOBER 10, 2024
The association between AF and various conditions—including hypertension, heart failure, sleep apnoea and chronic kidney disease—is well-described, highlighting that AF is often a multisystem disorder. 2 Before the.
DAIC
SEPTEMBER 11, 2024
A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. million U.S. adults, according to new estimates from University of California-San Francisco. Earlier projections had estimated that 3.3
Cardiometabolic Health Congress
JULY 25, 2024
Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C.
100 Open Heart
MARCH 23, 2023
Background Hypertension is a silent killer that causes serious health issues in all parts of the world. It is risk factor for cardiovascular disease, stroke and kidney disease. Self-monitoring practice has been identified as an important component of hypertension management. and then exported to SPSS V.25
Hypertension Journal
NOVEMBER 13, 2023
Hypertension, Ahead of Print. BACKGROUND:Polycystic kidney disease is the most common hereditary kidney disorder with early and frequent hypertension symptoms.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content